New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free

Follistatin 344

Also known as: FST-344, Follistatin, FST

Follistatin 344 is a recombinant form of the endogenous follistatin protein. It inhibits myostatin and activin — the primary negative regulators of muscle growth — potentially removing the genetic ceiling on muscle development. It is one of the most theoretically powerful anabolic compounds but is experimental with limited human data.

Half-Life

~24–36 hours

Route

SubQ, IM

Category

Anabolic & IGF

Studies

20 references

Key Benefits

  • Inhibits myostatin — removes muscle growth ceiling
  • Significant increases in muscle mass and strength
  • Reduces fat mass
  • Promotes bone density
  • May stimulate hair follicle cycling
  • Anti-fibrotic effects in muscle tissue
  • Synergistic with IGF-1 and other anabolic peptides

Mechanism of Action

Follistatin 344 works primarily by binding and neutralizing myostatin (GDF-8), a TGF-beta family member that limits muscle growth by inhibiting satellite cell activation and muscle protein synthesis. It also inhibits activin A and B, further disinhibiting muscle growth pathways. Animals with knocked-out myostatin genes develop dramatically larger muscles — follistatin mimics this effect pharmacologically. It may also promote bone density and hair follicle cycling.

Dosing Protocols

Experimental Protocol

Dose
100 mcg
Frequency
Once daily
Timing
Any time, subcutaneous
Cycle
10–30 days maximum

Very limited human pharmacokinetic data. Short cycles recommended given unknown long-term safety. Avoid near any reproductive organs or active injury sites due to activin inhibition effects.

Calculate your draw volume

Enter your vial size and BAC water to get exact injection volumes

Calculate dose →

Side Effects

  • Muscle soreness (from rapid hypertrophy)
  • Potential reproductive effects (activin inhibition)
  • Unknown long-term safety profile
  • Possible esophageal effects at high doses (animal data)

Contraindications

Pregnancy or planning pregnancy (activin plays a key role in reproduction). Active cancer. Experimental compound — limited human safety data.

Storage

Lyophilized powder: store at −20°C. Reconstituted: refrigerate at 2–8°C, use within 14 days.

  1. 1.
    Relationship Between High Serum Levels of Follistatin with Impaired Physical Function, and Severe Disease Activity in Rheumatoid Arthritis

    Gonzalez-Ponce F, Gamez-Nava JI, Jacobo-Cuevas H, Ponce-Guarneros JM, Valdivia-Tangarife ER, Nava-Valdivia CA et al. · International journal of molecular sciences · 2025PubMed Verified

  2. 2.
    Detection of black market follistatin 344

    Reichel C, Gmeiner G, Thevis M · Drug testing and analysis · 2020PubMed Verified

  3. 3.
    Central serous chorioretinopathy associated with high-dose follistatin-344: a retrospective case series

    Dağ U, Çağlayan M, Öncül H, Alakuş MF · International ophthalmology · 2020PubMed Verified

  4. 4.
    Detection of black market follistatin 344

    Reichel C, Gmeiner G, Thevis M · Drug testing and analysis · 2019PubMed Verified

  5. 5.
    The transgenic expression of human follistatin-344 increases skeletal muscle mass in pigs

    Chang F, Fang R, Wang M, Zhao X, Chang W, Zhang Z et al. · Transgenic research · 2017PubMed Verified

  6. 6.
    An engineered human follistatin variant: insights into the pharmacokinetic and pharmocodynamic relationships of a novel molecule with broad therapeutic potential

    Datta-Mannan A, Yaden B, Krishnan V, Jones BE, Croy JE · The Journal of pharmacology and experimental therapeutics · 2013PubMed Verified

  7. 7.
    The effects of transforming growth factor-β2 on the expression of follistatin and activin A in normal and glaucomatous human trabecular meshwork cells and tissues

    Fitzgerald AM, Benz C, Clark AF, Wordinger RJ · Investigative ophthalmology & visual science · 2012PubMed Verified

  8. 8.
    SNP analysis of follistatin gene associated with polycystic ovarian syndrome

    Panneerselvam P, Sivakumari K, Jayaprakash P, Srikanth R · Advances and applications in bioinformatics and chemistry : AABC · 2010PubMed Verified

  9. 9.
    Molecular cloning of cDNA for equine follistatin and its gene expression in the reproductive tissues of the mare

    Sugawara Y, Yamanouchi K, Naito K, Tachi C, Tojo H, Sawasaki T · The Journal of veterinary medical science · 1999PubMed Verified

  10. 10.
    Production of follistatin in porcine endothelial cells: differential regulation by bacterial compounds and the synthetic glucocorticoid RU 28362

    Michel U, Schneider O, Kirchhof C, Meisel S, Smirnov A, Wiltfang J et al. · Endocrinology · 1996PubMed Verified

  11. 11.
    Repression of glycoprotein hormone alpha-subunit gene expression and secretion by activin in alpha T3-1 cells

    Attardi B, Klatt B, Little G · Molecular endocrinology (Baltimore, Md.) · 1995PubMed Verified

  12. 12.
    Isolation and characterization of bovine follistatin cDNA

    Saleh M, Garcia S, Mercer JE, Findlay JK · Journal of molecular endocrinology · 1994PubMed Verified

  13. 13.
  14. 14.
  15. 15.
    Rat follistatin: ontogeny of steady-state mRNA levels in different tissues predicts organ-specific functions

    Michel U, Rao A, Findlay JK · Biochemical and biophysical research communications · 1991PubMed Verified

  16. 16.
    Rat follistatin: gonadal and extragonadal expression and evidence for alternative splicing

    Michel U, Albiston A, Findlay JK · Biochemical and biophysical research communications · 1990PubMed Verified

  17. 17.
    Intragonadal regulation of follicular maturation

    Tonetta SA, diZerega GS · Endocrine reviews · 1989ReviewPubMed Verified

  18. 18.
    Primary structure of the human follistatin precursor and its genomic organization

    Shimasaki S, Koga M, Esch F, Cooksey K, Mercado M, Koba A et al. · Proceedings of the National Academy of Sciences of the United States of America · 1988PubMed Verified

  19. 19.
    Porcine follistatin gene structure supports two forms of mature follistatin produced by alternative splicing

    Shimasaki S, Koga M, Esch F, Mercado M, Cooksey K, Koba A et al. · Biochemical and biophysical research communications · 1988PubMed Verified

  20. 20.
    Structural characterization of follistatin: a novel follicle-stimulating hormone release-inhibiting polypeptide from the gonad

    Esch FS, Shimasaki S, Mercado M, Cooksey K, Ling N, Ying S et al. · Molecular endocrinology (Baltimore, Md.) · 1987PubMed Verified

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice. Many compounds listed are research chemicals not approved for human use. Always consult a qualified healthcare professional before starting any protocol.

Was this page helpful?

Launching soon

Build and track your protocol in Staqk

Log doses, track timing, monitor biomarkers, and manage every compound in your stack — all in one place.

Free early access updates. No spam.